This is an R01 renewal proposal to study immune tolerance using custom designed super-antigens (Ags) reactive to immunoglobulin (Ig) constant regions. Immunological tolerance regulates unwanted responses of B and T cells to self- tissue, reducing the chances of autoimmunity and focusing the immune response on foreign antigens. SuperAgs facilitate the analysis of tolerance among normal, polyclonal populations of cells. In the present proposal, we make use of two transgenic models, one ubiquitously expressing superAg to IgM (IgM-macroself) and a second expressing in the liver a superAg to immunoglobulin ? light-chain (pAlb mice). IgM-macroself mice are a model of central tolerance in which B cell development is blocked at the immature B cell stage in the bone marrow and peripheral B cells are absent. In the pAlb model, B cells carrying ? L-chain are deleted in the periphery at a later, still semi- mature CD93+ transitional stage and fail to populate lymph nodes. Previous work has suggested that tolerance mechanisms at these checkpoints are distinct. We established a transposon insertional mutagenesis system to generate and identify mutant B cells in vivo that have escaped superAg-mediated tolerance. We identified a number of potential candidate genes and verified one candidate whose mutation allowed B cell escape. We propose to validate candidate genes regulating these two tolerance checkpoints, find additional candidates, evaluate in depth the role of Caspase 2, and investigate the use of genetic reprogramming to genetically capture escaped B cells and their mutations. The long-term goal of these studies is to develop a comprehensive understanding of all of the genetic components maintaining immune tolerance at these stages. This knowledge should facilitate treatment of autoimmune disorders and impact vaccine development.

Public Health Relevance

Mice expressing superantigens reactive to immunoglobulin constant regions on B cell receptors reveal immune tolerance checkpoints in a normal immune system. We exploit this selection to identify B cells that escape tolerance upon insertional mutagenesis with transposons. We propose to identify and characterize mutations that promote escape with the goal of understanding how autoreactive B cells are regulated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AI059714-14
Application #
9204809
Study Section
Transplantation, Tolerance, and Tumor Immunology (TTT)
Program Officer
Ferguson, Stacy E
Project Start
2004-02-01
Project End
2019-01-31
Budget Start
2017-02-01
Budget End
2018-01-31
Support Year
14
Fiscal Year
2017
Total Cost
$481,250
Indirect Cost
$231,250
Name
Scripps Research Institute
Department
Type
Research Institutes
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Nemazee, David (2017) Mechanisms of central tolerance for B cells. Nat Rev Immunol 17:281-294
Martinic, Marianne M; Caminschi, Irina; O'Keeffe, Meredith et al. (2017) The Bacterial Peptidoglycan-Sensing Molecules NOD1 and NOD2 Promote CD8+ Thymocyte Selection. J Immunol 198:2649-2660
Gonzalez-Martin, Alicia; Adams, Brian D; Lai, Maoyi et al. (2016) The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity. Nat Immunol 17:433-40
Lang, Julie; Ota, Takayuki; Kelly, Margot et al. (2016) Receptor editing and genetic variability in human autoreactive B cells. J Exp Med 213:93-108
Lai, Maoyi; Gonzalez-Martin, Alicia; Cooper, Anthony B et al. (2016) Regulation of B-cell development and tolerance by different members of the miR-17?92 family microRNAs. Nat Commun 7:12207
Aït-Azzouzene, Djemel; Kono, Dwight H; Gonzalez-Quintial, Rosana et al. (2010) Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice. J Immunol 185:1015-27